Regenerative Medical Technology Group Inc.
RMTG
$0.0486
$0.020975.45%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 24.33% | -2.90% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 24.33% | -2.90% | |||
| Cost of Revenue | -10.21% | 7.42% | |||
| Gross Profit | 41.79% | -7.40% | |||
| SG&A Expenses | 0.08% | 10.52% | |||
| Depreciation & Amortization | 6.99% | 8.36% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.11% | 9.48% | |||
| Operating Income | 112.11% | -133.25% | |||
| Income Before Tax | 57.28% | -5.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 57.28% | -5.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 57.28% | -5.89% | |||
| EBIT | 112.11% | -133.25% | |||
| EBITDA | 203.80% | -1,933.96% | |||
| EPS Basic | 57.40% | -5.86% | |||
| Normalized Basic EPS | 57.46% | -5.91% | |||
| EPS Diluted | 57.40% | -5.86% | |||
| Normalized Diluted EPS | 57.46% | -5.91% | |||
| Average Basic Shares Outstanding | 0.36% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.36% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
